Bristol Drug Seen Helping Body Attack Lung Cancer: HealthRobert Langreth
Bristol-Myers Squibb Co. is making progress developing a new drug to assist the body’s immune system in its ability to find and attack cancer cells. The drug may prove especially effective fighting lung cancer.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.